IVERMECTIN (ivermectin) by Teva is 12. Approved for inflammatory lesions of rosacea. First approved in 2022.
Drug data last refreshed 20h ago
12.1 Mechanism of Action The mechanism of action of ivermectin cream in treating rosacea lesions is unknown. 12.2 Pharmacodynamics Cardiac Electrophysiology At therapeutic doses, ivermectin cream is not expected to prolong QTc interval. 12.3 Pharmacokinetics Absorption The absorption of ivermectin…
Worked on IVERMECTIN at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer
Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis
Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies
Rosacea and Ivermectin